Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas
- PMID: 8685038
- DOI: 10.1016/S0344-0338(96)80126-9
Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas
Abstract
Tests for estrogen (ER) and progesterone (PR) receptors, c-erbB-2, p53 and Bcl-2 were made on paraffin sections of thirty-three cases of invasive micropapillary carcinoma (MPCa) of the breast. The relations between these proteins and general parameters and the patients' evolution, were analyzed and their statistical significance determined by Fisher's exact test. Follow up was available on twenty one patients of whom thirteen were alive after a mean of sixty months. Tumor size, metastatic nodes, c-erbB-2 and Bcl-2 all showed higher values in the dead patient group, but only nuclear grade and extensive lymphatic vessel invasion (LVI) were statistically significant prognostic factors. Hormone receptors and oncogenes were positive in quite similar figures to those of common breast cancers (NOSCa) and offered supplementary information about differentiation and cell atypia of individual cancers. Accordingly, ER (72.7%), PR (45.4%) and Bcl-2 (69.6%) were directly interrelated and inversely related with nuclear grade, mitotic grade, c-erbB-2 (36.3%) and p53 (12.1%). In conclusion, MPCa is a lymphotropic cancer phenotype whose prognosis can be influenced by known prognostic factors, including molecular. The lack of discriminative power between MPCa and NOSCa of ER, PR, c-erbB-2, p53, and Bcl-2 reinforces the importance of recognizing this particular type of cancer.
Similar articles
-
Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54.Pathol Res Pract. 2000;196(1):35-9. doi: 10.1016/S0344-0338(00)80019-9. Pathol Res Pract. 2000. PMID: 10674270
-
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.Anticancer Res. 1997 Mar-Apr;17(2B):1417-23. Anticancer Res. 1997. PMID: 9137508
-
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63. BMC Cancer. 2007. PMID: 17430582 Free PMC article.
-
Potential use of image analysis for the evaluation of cellular predicting factors for therapeutic response in breast cancers.Anal Quant Cytol Histol. 1997 Aug;19(4):316-28. Anal Quant Cytol Histol. 1997. PMID: 9267565 Review.
-
Molecular markers for predicting response to tamoxifen in breast cancer patients.Endocrine. 2000 Aug;13(1):1-10. doi: 10.1385/ENDO:13:1:1. Endocrine. 2000. PMID: 11051041 Review.
Cited by
-
Prediction of lymph node metastasis in patients with breast invasive micropapillary carcinoma based on machine learning and SHapley Additive exPlanations framework.Front Oncol. 2022 Sep 15;12:981059. doi: 10.3389/fonc.2022.981059. eCollection 2022. Front Oncol. 2022. PMID: 36185290 Free PMC article.
-
Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study.Medicine (Baltimore). 2020 Dec 11;99(50):e23487. doi: 10.1097/MD.0000000000023487. Medicine (Baltimore). 2020. PMID: 33327281 Free PMC article.
-
Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.Sci Rep. 2019 Jan 22;9(1):286. doi: 10.1038/s41598-018-36362-8. Sci Rep. 2019. PMID: 30670771 Free PMC article.
-
Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.BMC Cancer. 2018 Nov 8;18(1):1085. doi: 10.1186/s12885-018-4982-5. BMC Cancer. 2018. PMID: 30409127 Free PMC article.
-
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.BMC Cancer. 2017 Dec 28;17(1):895. doi: 10.1186/s12885-017-3897-x. BMC Cancer. 2017. PMID: 29281999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
